Skip to content

Home
Investor Information
About PAVAJ
Meet Our Team
News
Publications
Contact

Home
Investor Information
About PAVAJ
Meet Our Team
News
Publications
Contact

PAVAJ Vascular Selects Ascendia Pharmaceuticals to perform biomanufacturing.

Posted on September 5, 2025September 5, 2025 by pavaj

Posted in Biomanufacturing

Post navigation

Previous: PAVAJ Vascular obtains SBIR Phase 2 NIH grant R44DK13981 to start Biomanufacturing of 1,25 NPs.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Recent Posts

PAVAJ Vascular Selects Ascendia Pharmaceuticals to perform biomanufacturing.
PAVAJ Vascular obtains SBIR Phase 2 NIH grant R44DK13981 to start Biomanufacturing of 1,25 NPs.
PAVAJ Vascular Licenses New Technology

Archives

September 2025
July 2023

Categories

Biomanufacturing
New Technologies

PAVAJ Vascular
Rochester, MN

Home
Investor Information
About PAVAJ
Meet Our Team
News
Publications
Contact